Relevance of breast cancer cell lines as models for breast tumours: an update

被引:617
作者
Lacroix, M [1 ]
Leclercq, G [1 ]
机构
[1] Free Univ Brussels, Inst Jules Bordet, Lab Jean Claude Heuson Cancerol Mammaire, B-1000 Brussels, Belgium
关键词
breast cancer; cell lines; classification; estrogen receptor; gene expression; Her-2/neu; markers; models; tumours;
D O I
10.1023/B:BREA.0000014042.54925.cc
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The number of available breast cancer cell (BCC) lines is small, and only a very few of them have been extensively studied. Whether they are representative of the tumours from which they originated remains a matter of debate. Whether their diversity mirrors the well-known inter-tumoural heterogeneity is another essential question. While numerous similarities have long been found between cell lines and tumours, recent technical advances, including the use of micro-arrays and comparative genetic analysis, have brought new data to the discussion. This paper presents most of the BCC lines that have been described in some detail to date. It evaluates the accuracy of the few of them widely used (MCF-7, T-47D, BT-474, SK-BR-3, MDA-MB-231, Hs578T) as tumour models. It is concluded that BCC lines are likely to reflect, to a large extent, the features of cancer cells in vivo. The importance of oestrogen receptor-alpha (gene ESR1) and Her-2/neu (ERBB2) as classifiers for cell lines and tumours is underlined. The recourse to a larger set of cell lines is suggested since the exact origin of some of the widely used lines remains ambiguous. Investigations on additional specific lines are expected to improve our knowledge of BCC and of the dialogue that these maintain with their surrounding normal cells in vivo.
引用
收藏
页码:249 / 289
页数:41
相关论文
共 352 条
[1]   Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone [J].
Achuthan, R ;
Bell, SM ;
Roberts, P ;
Leek, JP ;
Horgan, K ;
Markham, AF ;
MacLennan, KA ;
Speirs, V .
CANCER GENETICS AND CYTOGENETICS, 2001, 130 (02) :166-172
[2]   Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells [J].
Ackland, ML ;
Newgreen, DF ;
Fridman, M ;
Waltham, MC ;
Arvanitis, A ;
Minichiello, J ;
Price, JT ;
Thompson, EW .
LABORATORY INVESTIGATION, 2003, 83 (03) :435-448
[3]   PMC42, a novel model for the differentiated human breast [J].
Ackland, ML ;
Michalczyk, A ;
Whitehead, RH .
EXPERIMENTAL CELL RESEARCH, 2001, 263 (01) :14-22
[4]  
Adeyinka A, 1999, INT J CANCER, V84, P370, DOI 10.1002/(SICI)1097-0215(19990820)84:4<370::AID-IJC7>3.3.CO
[5]  
2-Z
[6]  
Ahmadian M, 1997, CANCER RES, V57, P3664
[7]  
Akiri G, 2003, CANCER RES, V63, P1657
[8]  
Alpaugh ML, 1999, CANCER RES, V59, P5079
[9]   Relationship of sialyl-Lewisx/a underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma [J].
Alpaugh, ML ;
Tomlinson, JS ;
Ye, Y ;
Barsky, SH .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (02) :619-628
[10]   Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma [J].
Alpaugh, ML ;
Tomlinson, JS ;
Kasraeian, S ;
Barsky, SH .
ONCOGENE, 2002, 21 (22) :3631-3643